Gyrodyne , LLC (NASDAQ:GYRO) Short Interest Down 48.5% in July

Gyrodyne , LLC (NASDAQ:GYROGet Free Report) was the target of a large decrease in short interest during the month of July. As of July 31st, there was short interest totaling 362 shares, a decrease of 48.5% from the July 15th total of 703 shares. Based on an average trading volume of 2,039 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.0% of the company’s stock are sold short.

Gyrodyne Price Performance

GYRO stock traded down $0.04 during trading on Friday, hitting $5.40. 6,442 shares of the company’s stock were exchanged, compared to its average volume of 1,535. The business has a 50-day moving average price of $5.88 and a two-hundred day moving average price of $7.28. Gyrodyne has a 52-week low of $5.31 and a 52-week high of $11.00.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in Gyrodyne stock. Advisory Services Network LLC bought a new stake in Gyrodyne , LLC (NASDAQ:GYROFree Report) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 7,720 shares of the real estate investment trust’s stock, valued at approximately $77,000. Advisory Services Network LLC owned about 0.35% of Gyrodyne at the end of the most recent reporting period. Institutional investors and hedge funds own 71.36% of the company’s stock.

Gyrodyne Company Profile

(Get Free Report)

Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.

The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.

Featured Articles

Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.